Brexucabtagene autoleucel

Brexucabtagene autoleucel, known by its brand name Tecartus, is a specific treatment option for lymphoma that uses your own modified blood cells. First, your blood cells are collected through a process called leukapheresis, which is similar to donating blood. These cells are then specially prepared in a laboratory to target lymphoma cells. Once ready, they are given back to you as a single intravenous (IV) infusion, meaning they go directly into your bloodstream. This topic provides clear information about this treatment, helping you understand the process and what to expect.